Compare · BURU vs TMO
BURU vs TMO
Side-by-side comparison of Nuburu Inc. (BURU) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BURU operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $197.88B, about 10929.4x BURU ($18.1M).
- Over the past year, BURU is down 95.1% and TMO is up 28.1% - TMO leads by 123.2 points.
- TMO has been more active in the news (9 items in the past 4 weeks vs 8 for BURU).
- TMO has more recent analyst coverage (25 ratings vs 0 for BURU).
- Company
- Nuburu Inc.
- Thermo Fisher Scientific Inc
- Price
- $0.07-39.01%
- $532.16-2.05%
- Market cap
- $18.1M
- $197.88B
- 1M return
- -50.71%
- +12.59%
- 1Y return
- -95.09%
- +28.12%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- News (4w)
- 8
- 9
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BURU
- SEC Form 424B4 filed by Nuburu Inc.
- SEC Form EFFECT filed by Nuburu Inc.
- NUBURU Announces $38.0 Million Public Offering Priced at Approximately 30% Premium to Advance Tekne Acquisition and Retire Outstanding Indebtedness
- NUBURU Announces Proposed Premium-Priced Public Offering Expected to Provide Sufficient Funding to Consummate the Acquisition of a Controlling Interest in Tekne and Extinguish Outstanding Indebtedness and Related Stock-Based Amortizations
- SEC Form S-1 filed by Nuburu Inc.
- NUBURU Issues Letter to Shareholders on Transformation Plan Execution, Initial Revenue Generation and Industrial Platform Build-Out
- NUBURU Anticipates Stockholders' Equity to Materially Exceed NYSE American Requirement Based on Preliminary May 31 Review
- NUBURU Advances $2.2 Million Blue-Laser Rover Opportunity, Supporting Progress Toward 2026 Revenue Targets for Its LaserTech Business Line
- NUBURU Presents NUBURU Defense Italian Plan and Strengthens Strategic Team Following Golden Power Notification
- Nuburu Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target